2010 - TTS International Congress


This page contains exclusive content for the member of the following sections: TTS. Log in to view.

Innovation in Composite Tissue Transplantation

143.5 - What are the hallmarks of chronic rejection in composite tissue allotransplantation

Presenter: Palmina, Petruzzo, LYON, France
Authors: Petruzzo P., Badet L., Kanitakis J., Boutray S., Pialat J., Bureau du Colombier P., Gazarian A., Dubernard J., Morelon E.

WHAT ARE THE HALLMARKS OF CHRONIC REJECTION IN COMPOSITE TISSUE ALLOTRANSPLANTATION

INNOVATION IN COMPOSITE TISSUE TRANSPLANTATION

P. Petruzzo1, L. Badet1, J. Kanitakis2, S. Boutray3, J. Pialat4, P. Bureau du colombier5, A. Gazarian6, J.M. Dubernard1, E. Morelon1
1Dept Transplantation, Hopital Edouard Herriot, Lyon/FRANCE, 2Dept Dermatology, Hopital Edouard Herriot, Lyon/FRANCE, 3Inserm Research Unit 403, Claude Bernard Lyon I University, Lyon/FRANCE, 4Dept Radiology, Hopital Edouard Herriot, Lyon/FRANCE, 5Department Of Vascular Explorations, Hopital Edouard Herriot, Lyon/FRANCE, 68. chirurgie De La Main Et Du Membre Supérieur, Polyclinique Orthopédique de Lyon, Lyon/FRANCE

Body: Introduction
On the basis of clinical experience composite tissue allotransplantations (CTA) have shown little evidence of chronic rejection. Consequently, the course of chronic rejection on bones, joints,nerves, muscles, tendons and vessels may have yet undescribed implications.
Methods
In five bilateral hand allografted patients (10, 7, 3, 2 and 1 year of follow-up respectively) and in one facial allotransplantation (4 years of follow-up) all these structures were assessed byhistology, magnetic resonance imaging (MRI), ultrasonography, high resolution peripheral quantitative computed tomography scan (HR-pQCT) and nailfold capillary microscopy.
Results
None of the recipients showed macroscopic signs of rejection when the biopsies were performed. All the recipients presented normal skin structure without dermal fibrosis. In 3 hand grafted patients(seven, two and one year after transplantation) deeper biopsies were performed showing sparse interstitial lymphocytic infiltrate.
In the bilateral hand grafted patients MRI and HR-pQCT system were used to study some tissues of CTAs even though they showed some limits due to the artefacts caused by the presence of metallicmaterials.
HR-pQCT showed in male patients a decrease in trabecular density in recipient as well as in graft bones, while in graft radius the alterations involved also the cortices. The reported alterations ofbone structure seem to be correlated to several factors, such as nutrition and recipient BMI, immunosuppressive treatment (steroid dose), recipient and donor age.
Nerves and tendons did not show any specific alteration on MRI and ultrasonography in any hand grafted patients. Muscles were the only tissue that showed some modifications. Indeed, MRI evidenced avariable degree of muscular hypotrophy, particularly of intrinsic muscles, accompanied by fatty degeneration. These alterations were not considered as signs of chronic rejection.
In the facial transplantation no significant differences between recipient and graft soft tissues were detected by ultrasonography and MRI.
Vessels were patent, without thrombosis, stenosis or visible intimal hyperplasia. Ten years after the transplantation the first recipient performed an angiography, which did not detect any stenosisor alteration of arterial silhouette.
No specific alterations were detected in the nailfold capillaroscopy of the hand grafted patients.
In all bilateral hand transplantations an increase in the score system values over the follow-up period was noted, with no decrease in the sensorimotor recovery.
In the case of face transplantation the patient recovered normal opening and complete closure of the mouth, and disappearance of inferior lip hypotonus while orbicularis muscle recovery is stillimproving.
Conclusion
No signs of chronic graft rejection have been detected in these patients on triple drugs immunosuppressive regimen. However, the possibility that chronic rejection may develop in CTA exists,highlighting the necessity of close continuous follow-up of the patients.

Disclosure: All authors have declared no conflicts of interest.


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada